Silver Book Fact

The cost of age-related macular degeneration (AMD) is projected to increase to $845 million per year over the next 15 years, simply due to the growth in the number of older Americans.

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • The average cost in 2004 per age-related macular degeneration (AMD) patient age 40 and older using medications and vitamins was $110.  
  • An estimated 4,195,966 Americans age 40 and older have vision impairment and blindness—1,288,275 are blind and 2,907,691 have vision impairment.  
  • Vision conditions cause activity limitations in 8.9% of Americans age 85 and older.  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with glaucoma is $2.86 billion.  
  • Proportion of People with Diabetes with Diabetic Retinopathy of Any Severity, by Country
    Map figures are for both Type 1 and Type 2 diabetes.